EAN NewsEAN NewsTop Articles
European Academy of Neurology welcomes EMA approval of lecanemab for Alzheimer’s disease treatment
The EAN welcomes the European Medicine Agency’s decision to approve lecanemab for the treatment of early Alzheimer's disease, which provides a much-needed treatment opportunity for this devastating condition.